• About us
  • Donate
  • WADR
  • Contact us
  • Live Stream
Thursday, June 5, 2025
Loud Silence News
Advertisement
  • Ghana News
    • General News
    • Business
    • Education
    • Opinion
  • US News
    • Business
    • Health
    • Human Interest Stories
    • Politics
    • Education
  • Africa News
    • Business
    • Education
    • Health
    • Politics
  • ShowBiz
    • Ghana ShowBiz
    • US Showbiz
    • African ShowBiz
    • World Showbiz
  • Editorials
    • People
  • World News
    • Politics
    • Business
    • Education
    • Health
  • Sports
    • Ghana Sports
    • World Sports
  • WADR
No Result
View All Result
  • Ghana News
    • General News
    • Business
    • Education
    • Opinion
  • US News
    • Business
    • Health
    • Human Interest Stories
    • Politics
    • Education
  • Africa News
    • Business
    • Education
    • Health
    • Politics
  • ShowBiz
    • Ghana ShowBiz
    • US Showbiz
    • African ShowBiz
    • World Showbiz
  • Editorials
    • People
  • World News
    • Politics
    • Business
    • Education
    • Health
  • Sports
    • Ghana Sports
    • World Sports
  • WADR
No Result
View All Result
Loud Silence News
No Result
View All Result
Home US News US Health

COVID-19 Drug Testing: Where We Stand

Loud Silence Staff by Loud Silence Staff
April 21, 2020
in US Health
0
Obesity Ups Severe COVID-19 Risk in Young Patients
8
SHARES
42
VIEWS
Share on FacebookShare on TwitterShare on WhatsApp

[ad_1]

TUESDAY, April 21, 2020 (HealthDay News) — There’s a lot of confusion about medications and COVID-19, so experts offer some answers.

You might also like

May 5, 2020 — A roundup of the latest news about COVID-19

Carnival to Resume Some U.S.-Based Cruises

Students Upset by USMLE Response to COVID-19 Demand Changes

There are no proven drug treatments for the illness caused by the new coronavirus, so doctors sometimes use drugs approved for other conditions to treat seriously ill COVID-19 patients. This is called off-label use.

One drug being investigated as a possible COVID-19 treatment is hydroxychloroquine, which is approved by the U.S. Food and Drug Administration to treat malaria, but widely used to treat autoimmune diseases such as rheumatoid arthritis and lupus.

Hydroxychloroquine, often combined with the antibiotic azithromycin, has been touted as a potential treatment for COVID-19. Neither of the medications are antivirals, and the combination has been shown to cause heart problems in some patients.

Some people wonder if they should take hydroxychloroquine to prevent COVID-19. The answer is definitely no, said Chris Bland and Tim Brown, from the University of Georgia’s College of Pharmacy.

“I don’t believe at this time that anybody outside of the hospital setting should be a candidate for these two medications used together for COVID-19,” Bland said in a university news release.

“In the hospital, we can perform cardiac monitoring of these patients to ensure safety. There are very limited data for effectiveness with definite risk of cardiac toxicity,” Bland said. “That’s why we don’t recommend it to outpatients.”

The experimental antiviral drug remdesivir shows promise against COVID-19, but doesn’t yet have FDA approval for treating any condition. More research is needed to assess the drug’s effects on COVID-19, and several trials are underway around the world.

There are also claims that ibuprofen makes people more susceptible to the coronavirus and that ACE inhibitor drugs, used to treat high blood pressure and heart failure, increase the risk of poor outcomes in COVID-19 patients.

There’s no proof for either claim, Bland and Brown said.

They also warned that people who suddenly stop taking ACE inhibitors put themselves at risk for drastic blood pressure increases and worsening heart problems.

“One of the last places you want to be is admitted to the hospital where they could be potentially taking care of COVID-19 patients, and have a higher risk of exposure,” Bland said. “You never want to start or stop anything that is a chronic medication without talking to a health care provider, such as a pharmacist or your physician.”



[ad_2]

This content first appear on webmd

Tags: CoronavirusCOVID-19experimental drugshydroxycholoroquinepandemicpublic healthremdesevir
Previous Post

Covid-19: UK Death Toll 17,382 | Health

Next Post

March home sales drop 8.5% as sellers take properties off market

Loud Silence Staff

Loud Silence Staff

Related Posts

April 14, 2020 — A roundup of the latest news about COVID-19
US Health

May 5, 2020 — A roundup of the latest news about COVID-19

by Loud Silence Staff
May 6, 2020
US Health

Carnival to Resume Some U.S.-Based Cruises

by Loud Silence Staff
May 6, 2020
Why Clinicians’ Spiritual Health Matters in the COVID-19 Crisis
US Health

Students Upset by USMLE Response to COVID-19 Demand Changes

by Loud Silence Staff
May 5, 2020
As Society Reopens, Not Everyone is Ready
US Health

As Society Reopens, Not Everyone is Ready

by Loud Silence Staff
May 5, 2020
Why Clinicians’ Spiritual Health Matters in the COVID-19 Crisis
US Health

Why Your Kids Should Spend Time Outdoors

by Loud Silence Staff
May 5, 2020
Next Post
March home sales drop 8.5% as sellers take properties off market

March home sales drop 8.5% as sellers take properties off market

Recommended

Penguin Meets Up With Orangutan During Excursion In Empty San Diego Zoo

Penguin Meets Up With Orangutan During Excursion In Empty San Diego Zoo

May 1, 2020
CIA warned employees against Trump’s wonder drug

CIA warned employees against Trump’s wonder drug

April 14, 2020

Categories

  • African Business
  • African Education
  • African Health
  • African News
  • African Politics
  • African ShowBiz
  • Education
  • Ghana Business
  • Ghana News
  • Ghana ShowBiz
  • Ghana Sports
  • Human Interest Stories
  • News
  • Opinion
  • People
  • ShowBiz
  • Social Trends
  • US Business
  • US Education
  • US Health
  • US News
  • US Politics
  • US Showbiz
  • WADR
  • World Business
  • World News
  • World Politics
  • World Showbiz
  • World Sports

Don't miss it

President Mahama Unveils 24-Hour Economy Plan, Set to roll out in July
Ghana News

President Mahama Unveils 24-Hour Economy Plan, Set to roll out in July

May 28, 2025
Unmasking the Propaganda Machine: The Coordinated Smear Campaign Against Dr. Anne Sansa Daly
Ghana News

Ghana’s Medical and Dental Council Clarifies Stance on Dr. Anne Sansa Daly’s Certification

May 26, 2025
Nii Armah Amarteifio Apologizes to Dr. Daly
Ghana News

Nii Armah Amarteifio Apologizes to Dr. Daly

May 24, 2025
Unmasking the Propaganda Machine: The Coordinated Smear Campaign Against Dr. Anne Sansa Daly
Ghana News

Unmasking the Propaganda Machine: The Coordinated Smear Campaign Against Dr. Anne Sansa Daly

May 23, 2025
Legal Notice: Demand for Retraction of Defamatory Publication
Ghana News

Legal Notice: Demand for Retraction of Defamatory Publication

May 23, 2025
Legal Notice: Demand for Retraction of Defamatory Publication
Ghana News

Legal Notice: Demand for Retraction of Defamatory Publication

May 23, 2025

About Us

LOGO

Loud Silence Radio & TV Network and is a multi media production company focusing on Ghanaian and African news.

Contact

  • Alexandria, Virginia, USA
  • +1 212-602-9641
  • loudsilenceradio@gmail.com
Facebook Twitter Youtube Linkedin

Download App

google play store

© 2021 Loud Silence Media. All rights reserved.

  • About us
  • Contact us
  • Donate
  • Live Stream
  • Privacy Policy
  • Terms of Use
Menu
  • About us
  • Contact us
  • Donate
  • Live Stream
  • Privacy Policy
  • Terms of Use
No Result
View All Result
  • Ghana News
    • General News
    • Business
    • Education
    • Opinion
  • US News
    • Business
    • Health
    • Human Interest Stories
    • Politics
    • Education
  • Africa News
    • Business
    • Education
    • Health
    • Politics
  • ShowBiz
    • Ghana ShowBiz
    • US Showbiz
    • African ShowBiz
    • World Showbiz
  • Editorials
    • People
  • World News
    • Politics
    • Business
    • Education
    • Health
  • Sports
    • Ghana Sports
    • World Sports
  • WADR
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.